Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v2-FR
Language English French
Date Updated 2022-09-10 2022-03-03
Drug Identification Number 02502372 02502372
Brand name TOBRAMYCIN INJECTION USP TOBRAMYCIN INJECTION USP
Common or Proper name TOBRAMYCIN FOR INJECTION USP TOBRAMYCIN FOR INJECTION USP
Company Name STERIMAX INC STERIMAX INC
Ingredients TOBRAMYCIN TOBRAMYCIN
Strength(s) 40MG 40MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 25 VIALS 25 VIALS
ATC code J01GB J01GB
ATC description AMINOGLYCOSIDE ANTIBACTERIALS AMINOGLYCOSIDE ANTIBACTERIALS
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2021-06-21 2021-06-21
Estimated end date Unknown Unknown
Actual end date 2022-09-09
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Product will be available at McKesson by end of next week.
Health Canada comments